Magazine

Specialized publication dedicated to Good Manufacturing Practice, modernization of pharmaceutical production, and modern pharmaceutical manufacturing technologies

TOP News

Biocon’s Insulin Plant in Malaysia Receives EIR from FDA with VAI Classification

Biocon reported the FDA has closed the pre-inspection of the plant for its insulin glargine, tagging the facility with a voluntary action indicated (VAI), a rating that indicates the facility meets at...

Novartis and Aurobindo Pharma Terminated their $1 billion Transaction

Novartis announced the mutual agreement with Aurobindo Pharma USA Inc. to terminate the agreement to sell the Sandoz US generic oral solids and dermatology businesses to Aurobindo Pharma USA Inc. This...

FDA-Approved Drug Contains Active Ingredient from Genetically Engineered Animal

The U.S. Food and Drug Administration approved Sevenfact for the treatment and control of bleeding episodes occurring in adults and adolescents 12 years of age and older with hemophilia A or B with i...

The Medicine Against RNA-dependent Viruses has Passed the First Phase of Clinical Trials

Scientists of the Center for Pharmaceutical and Chemical Technologies of Ural Federal University together with colleagues from the Institute of Organic Synthesis named after I. Ya. Postovsky UrB RAS s...

Collaborate on Next-Generation Dual-Targeting CAR T Therapies in Multiple Myeloma

Kite, a Gilead Company, and Teneobio, Inc. announced the companies have entered into a license and collaboration agreement through which Kite will receive exclusive rights to certain antibodies direct...

BMS Receives Positive CHMP Opinion Recommending Approval of ZEPOSIA® (ozanimod)

Bristol Myers Squibb announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion for ZEPOSIA® (ozanimod) for the treatment ...

Pre-clinical Trials of the Russian Vaccine’s Specific Activity Will Be Held before June 22

lab research
Russia will complete pre-clinical trials of the vaccines against the novel coronavirus (COVID-19) developed at the Vector State Research Center of Virology and Biotechnology in Novosibirsk before June...

Subscribe to GMP news Newsletter!

Interview

Pharma Is Under Control

Director of FSI “SID and GP” of the Ministry of Industry and Trade of the Russian Federation on the work of the Russian State GMP Inspectorate. Before entering the local market all foreign drugs un...

Team of Sechenov University Scientists to Make Presentation at the IFAA 2019 Congress in London

A team of Sechenov University scientists will present their research on the future of artificial intelligence in anatomy at the annual Congress of the International Federation of Associations of Anato...

SID&GP about MoU and Relatioship with UK

On January 29, the UK and Russia have signed a memorandum of understanding enhancing cooperation in the field of regulation of medicines. Radio Sputnik discussed the development with Nikolay Tsatsy...

InterPharm Technology Group®. Exceeding the expectations over 20 years

For 20 years, InterPharmTechnology Group® holds a prominent position in the market of pharmaceutical technological equipment in Russia and other EAEU member states.

Subscribe to GMP news Newsletter!

Magazine

Specialized publication dedicated to Good Manufacturing Practice, modernization of pharmaceutical production, and modern pharmaceutical manufacturing technologies